ChartMill assigns a Buy % Consensus number of 83% to GDTC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-10 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-06-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-12-04 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-07-21 | Benchmark | Initiate | Speculative Buy |
The consensus rating for CYTOMED THERAPEUTICS LTD (GDTC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CYTOMED THERAPEUTICS LTD (GDTC) is 7.